Cargando…
Solid organ graft-versus-host disease in a recipient of a COVID-19 positive liver graft
A 66-year-old male with end-stage liver disease (ESLD) secondary to non-alcoholic fatty liver disease (NAFLD), complicated by hepatocellular carcinoma (HCC), underwent deceased donor liver transplantation from a Coronavirus disease 2019 (COVID-19) positive donor. He presented a month later with feve...
Autores principales: | Ashcherkin, N, Pisipati, S, Athale, J, Carey, EJ, Chascsa, D, Adamski, J, Shah, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Masson SAS.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114352/ https://www.ncbi.nlm.nih.gov/pubmed/38013675 http://dx.doi.org/10.1016/j.liver.2023.100154 |
Ejemplares similares
-
Treatment of Acute Graft-versus-Host Disease in Liver Transplant Recipients
por: Kim, Edward, et al.
Publicado: (2021) -
Graft-versus-host disease after liver transplantation
por: Chaib, Eleazar, et al.
Publicado: (2011) -
Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients
por: Chen, Chien-Ting, et al.
Publicado: (2017) -
Differences in Liver Graft Survival by Recipient Sex
por: De Simone, Alexia I., et al.
Publicado: (2020) -
T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor
por: Jiang, Hua, et al.
Publicado: (2021)